HBIO RSI Chart
Last 7 days
-16.9%
Last 30 days
-11.5%
Last 90 days
-20.0%
Trailing 12 Months
-24.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 114.5M | 114.1M | 112.5M | 112.3M |
2022 | 120.7M | 120.7M | 118.0M | 113.3M |
2021 | 105.3M | 111.2M | 116.8M | 118.9M |
2020 | 111.7M | 105.5M | 102.1M | 102.1M |
2019 | 122.2M | 120.3M | 119.1M | 116.2M |
2018 | 86.1M | 98.6M | 108.6M | 120.8M |
2017 | 95.6M | 88.5M | 82.2M | 77.4M |
2016 | 109.9M | 107.2M | 106.5M | 104.5M |
2015 | 108.5M | 110.4M | 110.7M | 108.7M |
2014 | 105.0M | 105.8M | 106.2M | 108.7M |
2013 | 108.9M | 106.5M | 105.6M | 105.2M |
2012 | 110.9M | 112.2M | 112.0M | 111.2M |
2011 | 108.2M | 109.4M | 109.4M | 108.9M |
2010 | 0 | 93.2M | 100.7M | 108.2M |
2009 | 0 | 0 | 0 | 85.8M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 06, 2024 | cote jennifer | sold (taxes) | -40,771 | 4.11 | -9,920 | chief financial officer |
Mar 05, 2024 | green james w | acquired | - | - | 429,594 | chief executive officer |
Mar 05, 2024 | cote jennifer | acquired | - | - | 71,600 | chief financial officer |
Dec 31, 2023 | green james w | sold (taxes) | -442,926 | 5.35 | -82,790 | chief executive officer |
Dec 29, 2023 | green james w | sold (taxes) | -686,897 | 5.35 | -128,392 | chief executive officer |
Dec 29, 2023 | cote jennifer | sold (taxes) | -31,618 | 5.35 | -5,910 | chief financial officer |
Aug 17, 2023 | green james w | bought | 109,500 | 4.38 | 25,000 | chief executive officer |
Jun 11, 2023 | green james w | sold (taxes) | -264,117 | 5.46 | -48,373 | chief executive officer |
May 22, 2023 | edrick alan i | acquired | - | - | 25,554 | - |
May 22, 2023 | eade katherine a. | acquired | - | - | 25,554 | - |
Which funds bought or sold HBIO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 19, 2024 | Riverwater Partners LLC | added | 14.07 | -41,967 | 395,155 | 0.29% |
Apr 16, 2024 | TSFG, LLC | unchanged | - | -1,000 | 1,000 | -% |
Apr 16, 2024 | Pasadena Private Wealth, LLC | unchanged | - | -191,459 | 731,336 | 0.17% |
Apr 15, 2024 | Legato Capital Management LLC | added | 9.4 | -22,772 | 148,519 | 0.02% |
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | new | - | 118 | 118 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 1.85 | 2,371,830 | 11,248,800 | -% |
Mar 07, 2024 | Brown Shipley& Co Ltd | unchanged | - | 5,022 | 25,589 | 0.01% |
Mar 05, 2024 | GREENWOOD CAPITAL ASSOCIATES LLC | added | 92.2 | 1,373,340 | 2,360,450 | 0.15% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 165 | 300,294 | 430,932 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 0.78 | 21,826 | 107,813 | -% |
Unveiling Harvard Bioscience Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Harvard Bioscience Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 185.8B | 40.1B | 32.46 | 4.63 | ||||
BDX | 67.6B | 19.5B | 53.86 | 3.47 | ||||
ALGN | 22.6B | 3.9B | 50.76 | 5.85 | ||||
BAX | 20.5B | 14.8B | 7.72 | 1.39 | ||||
MID-CAP | ||||||||
ATR | 9.3B | 3.5B | 32.56 | 2.66 | ||||
HSIC | 9.3B | 12.3B | 22.25 | 0.75 | ||||
BIO | 8.2B | 2.7B | -12.83 | 3.06 | ||||
XRAY | 6.3B | 4.0B | -46.81 | 1.59 | ||||
AXNX | 3.4B | 366.4M | -561.72 | 9.3 | ||||
PDCO | 2.3B | 6.6B | 11.99 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.88 | 0.4 | ||||
ANIK | 385.4M | 166.7M | -4.66 | 2.31 | ||||
ANGO | 250.7M | 324.0M | -1.3 | 0.77 | ||||
APYX | 44.0M | 52.3M | -2.35 | 0.84 | ||||
AEMD | 3.9M | 3.7M | -0.32 | 1.03 |
Harvard Bioscience Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 11.0% | 28,153 | 25,363 | 28,759 | 29,975 | 28,427 | 26,922 | 29,208 | 28,778 | 33,055 | 29,663 | 29,197 | 26,989 | 30,984 | 24,037 | 23,308 | 23,771 | 30,972 | 27,418 | 29,584 | 28,202 | 33,858 |
Gross Profit | 10.9% | 16,325 | 14,727 | 16,673 | 18,346 | 15,833 | 12,172 | 16,637 | 16,177 | 19,560 | 16,308 | 16,353 | 15,431 | 17,708 | 13,495 | 13,856 | 12,982 | 17,234 | 14,979 | 15,955 | 16,154 | 18,740 |
Operating Expenses | 2.4% | 16,043 | 15,660 | 15,877 | 16,597 | 16,290 | 15,934 | 12,639 | 22,889 | 17,861 | 15,760 | 16,295 | 15,670 | 14,952 | 13,313 | 13,300 | 16,255 | 15,601 | 16,344 | 15,727 | 16,274 | 16,998 |
S&GA Expenses | 8.5% | 6,220 | 5,732 | 6,178 | 5,978 | 5,948 | 5,819 | 6,587 | 6,687 | 7,343 | 6,183 | 5,730 | 5,386 | 5,470 | 4,588 | 4,279 | 5,579 | 5,894 | 5,294 | 5,770 | 6,306 | 6,467 |
R&D Expenses | 14.1% | 3,150 | 2,760 | 2,957 | 2,897 | 2,849 | 2,763 | 3,497 | 3,220 | 2,951 | 2,660 | 2,701 | 2,487 | 2,349 | 1,949 | 1,897 | 2,490 | 2,645 | 2,564 | 2,771 | 2,735 | 3,045 |
EBITDA Margin | -4.0% | 0.02* | 0.03* | -0.01* | 0.03* | -0.05* | -0.03* | 0.01* | -0.03* | 0.03* | 0.02* | 0.02* | 0.02* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -8.0% | 789 | 858 | 976 | 1,172 | 785 | 684 | 462 | 383 | 741 | 2.00 | 376 | 458 | 1,086 | 1,246 | 1,312 | 1,237 | 1,318 | 1,348 | 1,376 | 1,406 | 1,152 |
Income Taxes | 3.2% | 699 | 677 | -1,100 | 600 | 737 | -1,285 | 986 | -100 | 167 | 200 | -200 | -15.00 | 43.00 | -317 | 713 | 55.00 | -452 | -100 | -885 | 576 | -3,260 |
Earnings Before Taxes | -96.3% | -1,103 | -562 | -2,098 | 1,207 | -892 | -4,690 | 3,421 | -7,018 | 1,131 | 45.00 | -632 | -684 | -548 | -1,415 | -868 | -4,461 | 98.00 | -2,674 | -1,132 | -1,794 | 45.00 |
EBT Margin | -9.3% | -0.02* | -0.02* | -0.06* | -0.01* | -0.08* | -0.06* | -0.02* | -0.05* | 0.00* | -0.02* | -0.03* | -0.03* | - | - | - | - | - | - | - | - | - |
Net Income | -46.7% | -1,818 | -1,239 | -980 | 622 | -1,666 | -3,405 | 2,435 | -6,880 | 961 | -170 | -410 | -669 | -615 | -1,098 | -1,581 | -4,516 | 550 | -2,620 | -247 | -2,370 | 2,862 |
Net Income Margin | -4.9% | -0.03* | -0.03* | -0.05* | -0.02* | -0.08* | -0.06* | -0.03* | -0.05* | 0.00* | -0.02* | -0.03* | -0.04* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -16.2% | 3,473 | 4,144 | 3,035 | 1,588 | 2,444 | 207 | -632 | -2,457 | -241 | -1,140 | 562 | 886 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -1.7% | 137 | 140 | 143 | 146 | 145 | 147 | 155 | 158 | 162 | 154 | 154 | 151 | 156 | 150 | 151 | 156 | 165 | 163 | 166 | 171 | 169 |
Current Assets | -2.9% | 49.00 | 50.00 | 53.00 | 52.00 | 51.00 | 52.00 | 56.00 | 59.00 | 62.00 | 56.00 | 54.00 | 49.00 | 52.00 | 44.00 | 44.00 | 48.00 | 54.00 | 52.00 | 52.00 | 54.00 | 58.00 |
Cash Equivalents | -19.8% | 4.00 | 5.00 | 4.00 | 4.00 | 5.00 | 5.00 | 4.00 | 5.00 | 8.00 | 6.00 | 6.00 | 6.00 | 8.00 | 3.00 | 3.00 | 6.00 | 8.00 | 7.00 | 5.00 | 5.00 | 8.00 |
Inventory | -4.3% | 25.00 | 26.00 | 26.00 | 27.00 | 26.00 | 26.00 | 29.00 | 29.00 | 28.00 | 26.00 | 25.00 | 23.00 | 22.00 | 23.00 | 23.00 | 23.00 | 22.00 | 24.00 | 25.00 | 27.00 | 25.00 |
Net PPE | 18.6% | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 6.00 | 6.00 |
Goodwill | 1.5% | 57.00 | 56.00 | 57.00 | 57.00 | 56.00 | 55.00 | 56.00 | 57.00 | 58.00 | 58.00 | 58.00 | 58.00 | 59.00 | 58.00 | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 |
Liabilities | -1.8% | 64.00 | 65.00 | 68.00 | 71.00 | 73.00 | 75.00 | 78.00 | 82.00 | 79.00 | 77.00 | 75.00 | 74.00 | 80.00 | 72.00 | 75.00 | 80.00 | 83.00 | 86.00 | 86.00 | 91.00 | 86.00 |
Current Liabilities | 9.7% | 27.00 | 24.00 | 23.00 | 23.00 | 23.00 | 21.00 | 23.00 | 27.00 | 25.00 | 24.00 | 23.00 | 21.00 | 21.00 | 21.00 | 23.00 | 23.00 | 25.00 | 22.00 | 21.00 | 24.00 | 25.00 |
Long Term Debt | -13.0% | 31.00 | 35.00 | 38.00 | 41.00 | 43.00 | 47.00 | 46.00 | 46.00 | 45.00 | 43.00 | 41.00 | 42.00 | 46.00 | 41.00 | 41.00 | 46.00 | 47.00 | 52.00 | 52.00 | 54.00 | 55.00 |
LT Debt, Non Current | -13.0% | 31.00 | 35.00 | 38.00 | 41.00 | 43.00 | 47.00 | 46.00 | 46.00 | 45.00 | 43.00 | 41.00 | 42.00 | 46.00 | 41.00 | 41.00 | 46.00 | 47.00 | 52.00 | 52.00 | 54.00 | 55.00 |
Shareholder's Equity | -1.6% | 73.00 | 74.00 | 75.00 | 74.00 | 72.00 | 72.00 | 78.00 | 76.00 | 83.00 | 77.00 | 79.00 | 77.00 | 77.00 | 77.00 | 76.00 | 76.00 | 82.00 | 77.00 | 80.00 | 80.00 | 83.00 |
Retained Earnings | -1.3% | -145 | -143 | -142 | -141 | -142 | -140 | -137 | -139 | -132 | -133 | -133 | -133 | -132 | -131 | -130 | -129 | -124 | -125 | -122 | -122 | -119 |
Additional Paid-In Capital | -0.2% | 232 | 233 | 232 | 230 | 229 | 228 | 227 | 226 | 226 | 225 | 226 | 235 | 232 | 231 | 231 | 230 | 229 | 228 | 227 | 227 | 226 |
Shares Outstanding | 1.7% | 43.00 | 43.00 | 43.00 | 42.00 | 42.00 | 41.00 | 41.00 | 41.00 | 41.00 | 41.00 | 40.00 | 40.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 219 | - | - | - | 142 | - | - | - | 324 | - | - | - | 116 | - | - | - | 73.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -1.3% | 4,303 | 4,361 | 3,552 | 1,812 | 2,679 | 649 | -190 | -1,986 | 117 | -660 | 768 | 1,037 | 2,490 | 1,597 | 2,373 | 2,871 | 2,220 | 3,158 | 657 | 2,010 | 2,593 |
Share Based Compensation | 1.4% | 1,382 | 1,363 | 1,102 | 1,153 | 1,010 | 1,139 | 1,239 | 1,023 | 1,033 | 1,004 | 1,164 | 968 | 1,006 | 1,079 | 769 | 793 | 841 | 987 | 615 | 591 | - |
Cashflow From Investing | -164.6% | -1,061 | -401 | -625 | 288 | -235 | -442 | -442 | -471 | -358 | -480 | -206 | -301 | -314 | -564 | -283 | -241 | -456 | -361 | 740 | -152 | -627 |
Cashflow From Financing | -49.7% | -4,116 | -2,750 | -2,375 | -2,893 | -2,730 | 377 | -578 | 94.00 | 2,594 | 487 | -192 | -3,141 | 3,357 | -953 | -5,300 | -5,071 | -429 | -658 | -1,533 | -5,004 | -354 |
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenues | $ 112,250 | $ 113,335 |
Cost of revenues | 46,179 | 52,516 |
Gross profit | 66,071 | 60,819 |
Sales and marketing expenses | 24,108 | 25,041 |
General and administrative expenses | 22,780 | 24,493 |
Research and development expenses | 11,764 | 12,329 |
Amortization of intangible assets | 5,525 | 6,122 |
Litigation settlement - Note 16 | 0 | (233) |
Total operating expenses | 64,177 | 67,752 |
Operating income (loss) | 1,894 | (6,933) |
Other (expense) income: | ||
Interest expense | (3,591) | (2,548) |
Unrealized loss on equity securities - Note 16 | (632) | 0 |
Other (expense) income, net | (227) | 302 |
Total other expense | (4,450) | (2,246) |
Loss before income taxes | (2,556) | (9,179) |
Income tax expense | 859 | 337 |
Net loss | $ (3,415) | $ (9,516) |
Loss per share: | ||
Basic and diluted loss per share (in dollars per share) | $ (0.08) | $ (0.23) |
Weighted-average common shares: | ||
Basic and diluted (in shares) | 42,420 | 41,413 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 4,283 | $ 4,508 |
Accounts receivable, net | 16,099 | 16,705 |
Inventories | 24,716 | 26,439 |
Other current assets | 3,940 | 3,472 |
Total current assets | 49,038 | 51,124 |
Property, plant and equipment, net | 3,981 | 3,366 |
Operating lease right-of-use assets | 4,773 | 5,816 |
Goodwill | 57,065 | 56,260 |
Intangible assets, net | 16,036 | 21,014 |
Other long-term assets | 6,473 | 7,780 |
Total assets | 137,366 | 145,360 |
Current liabilities: | ||
Current portion of long-term debt | 5,859 | 3,811 |
Current portion of operating lease liabilities | 1,416 | 2,135 |
Accounts payable | 5,554 | 6,447 |
Contract liabilities | 4,508 | 3,370 |
Other current liabilities | 9,205 | 7,486 |
Total current liabilities | 26,542 | 23,249 |
Long-term debt, net | 30,704 | 43,013 |
Deferred tax liability | 776 | 590 |
Operating lease liabilities | 4,794 | 5,282 |
Other long-term liabilities | 1,476 | 1,006 |
Total liabilities | 64,292 | 73,140 |
Commitments and contingencies - Note 15 | ||
Stockholders' equity: | ||
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized | 0 | 0 |
Common stock, par value $0.01 per share, 80,000,000 shares authorized: 43,394,509 shares issued and outstanding at December 31, 2023; 42,081,707 shares issued and outstanding at December 31, 2022 | 434 | 454 |
Additional paid-in-capital | 232,435 | 229,008 |
Accumulated deficit | (145,605) | (142,190) |
Accumulated other comprehensive loss | (14,190) | (15,052) |
Total stockholders' equity | 73,074 | 72,220 |
Total liabilities and stockholders' equity | $ 137,366 | $ 145,360 |